Abingdon, United Kingdom

Mirco Meniconi

This inventor holds 6 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Padlock Therapeutics, Inc., Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mirco Meniconi. Retrieved from https://idiyas.com/inventor/mirco-meniconi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mirco Meniconi: Innovator in PAD4 Inhibition

Introduction

Mirco Meniconi is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for PAD4-related disorders. With a total of 6 patents to his name, Meniconi's work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Among his latest patents, Meniconi has developed compounds that serve as heteroaryl inhibitors of PAD4. These inventions provide valuable compositions and methods for treating disorders associated with PAD4. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Meniconi has worked with esteemed organizations such as Padlock Therapeutics, Inc. and the Max Planck Society for the Advancement of Science. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Meniconi has collaborated with talented individuals, including Heather Tye and Rajesh Devraj. These partnerships have enriched his research and fostered a collaborative environment for innovation.

Conclusion

Mirco Meniconi's contributions to the field of PAD4 inhibition highlight his role as a significant inventor. His patents and collaborations reflect his dedication to advancing medical research and improving treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…